Company profilePharmaceutical#469 of 1,318 in Pakistan✓ No DRAP alerts

Lakhani Pharma (Pvt.) Limited

Pharmaceutical company · 31 brands · 18 molecules

31 registered products 33 pharmaceutical brands 18 distinct molecules 0 DRAP alerts

Company overview

31
registered products
33
pharmaceutical brands
18
distinct molecules
0
therapeutic classes
0
DRAP alerts

Lakhani Pharma (Pvt.) Limited is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 31 product registrations across 18 distinct molecules. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by Lakhani

32 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

32
ceilings with an approval date
0
not revised in 2+ years
2026
oldest approval year
202632

Top molecules by brand count

Sterile Water For Injection3 brands
Chloride2 brands
Glucose ...... 100 Mg1 brand
Glucose ...... 50 Mg1 brand
Glucose ...... 250 Mg1 brand
Calcium Chloride ...... 0.033 G1 brand
Sodium Chloride ...... 0.45 Gm1 brand
Sodium Chloride........0.9Gm1 brand

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official42 products · Rs 17.03 – Rs 1,555.83
Median across source: Rs 116.65

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

PACIFIC PHARMACEUTICALS LTD. holds 79 molecules not in this portfolio
AcipimoxAlprazolamAluminium HydroxideAluminium Hydroxide And OxideAmmonium CarbonateAprepitant
FRONTIER DEXTROSE LIMITED holds 19 molecules not in this portfolio
CiprofloxacinDextroseDextrose 4.3%Dextrose 5%Dextrose Iv SolutionLevofloxacin
Medipak (Pvt) Ltd holds 78 molecules not in this portfolio
000 I.UAdenosine Containing Eye PrepsAdernaline 1MgAminoacid PrepsAprepitantAscorbic Acid

Get the full profile for Lakhani

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.